Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EmpiraMed is a healthcare technology company that specializes in generating real-world evidence (RWE) through its proprietary PROmpt platform. The company focuses on capturing patient-reported outcomes (PROs) and clinical data to support observational studies, clinical trials, and post-market surveillance. By utilizing mobile health (mHealth) and automated patient engagement tools, EmpiraMed helps life science companies demonstrate the value and effectiveness of their therapies in real-world settings. Their solutions are primarily used in chronic disease areas such as neurology, immunology, and oncology to improve data quality and patient compliance. The platform is designed to reduce the cost and time required to execute traditional site-based clinical studies by leveraging decentralized data collection methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EmpiraMed.